Anti-infective Drugs Market to be Propelled by the High Incidence of Infectious Diseases

Anti-infective Drugs Market: Snapshot

The global anti-infective drugs market is driven by increase in prevalence of infectious diseases across the globe. The global market was valued at US$ 106.5 Bn in 2016 and is projected to expand at a CAGR of 4.2% from 2017 to 2025 to reach US$ 153.3 Bn by 2025. Growth of the market is attributed to increase in digitization of dental practices, high health care IT budgets, and rise in demand for chair time optimization in developed markets.

In terms of indication, the global anti-infective drugs market has been classified into pneumonia, methicillin-resistant Staphylococcus aureus (MRSA), sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, HIV infection, respiratory virus infection, and others. The HIV infection segment dominated the global market and the trend is likely to continue by the end of 2025 with marginal increase in market share. The HIV infection segment is projected to dominate the global anti-infective drugs market as these drugs are administered to patients for the lifetime and new and effective treatments are being introduced. Based on distribution channel, the global market has been divided into hospital pharmacy, retail pharmacy and online pharmacy.

Geographically, the global anti-infective drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market and is projected to lose market share by the end of 2025. The region’s dominance of the global anti-infective drugs market is due to factors such as increase in adoption of advanced and high cost drug therapies and significant treatment penetration. Moreover, patients with HIV infection and hepatitis virus infection have increased in the U.S. This is projected to fuel the growth of the anti-infective drugs market in the country during the forecast period. Asia Pacific is projected to be the fastest growing market for anti-infective drugs during the forecast period. India dominated the anti-infective drugs market in the region, whereas Japan is estimated to grow at a high CAGR during the forecast period.

Perceive the Sample of the Report:

Key players in the global anti-infective drugs market include Merck & Co., Inc., Bayer AG, Pfizer, Inc., Gilead Sciences, GlaxoSmithKline plc, Novartis AG, Bristol-Myers Squibb, Sanofi, Allergen plc, F. Hoffman-La Roche Ltd., and Johnson and Johnson. Companies are adopting the strategy acquisition and collaboration to improve and strengthen geographic presence.

Posted in

Ganesh Rajput

As one of the lead news writers on CMFE News, Ganesh’s specialization lies in the science and technology domains. His passion for the latest developments in cloud technology, connected devices, nanotechnology, and virtual reality, among others, shines through in the most recent industry coverage he provides. Ganesh’s take on the impact of digital technologies across the science, technology, and business domains gives his writing a fresh and modern outlook.

Leave a Reply